Position in PGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,526,367
+$1,721,820 QoQ
Shares Held
911,206
+111.1% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Corient Private Wealth LLC holds $187,873,632 across 105 Biotechnology names. PGEN ranks #12 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
86,492 | $38,622,137 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
196,599 | $14,762,618 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,073 | $13,963,922 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
190,684 | $12,323,906 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,718 | $8,509,313 | |
| 6 | OMER |
Omeros Corp
|
801,411 | $8,462,900 | |
| 7 | RPRX |
Royalty Pharma plc
|
116,377 | $5,582,604 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
719,582 | $5,008,290 |
All Filings in PGEN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,526,367 | 911,206 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,804,547 | 431,710 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $2,624,008 | 797,571 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,014,861 | 714,691 | Shares | Sole | 2025-09-26 | |
| 2025-03-31 | $1,064,889 | 714,691 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $687,647 | 613,971 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $584,222 | 614,971 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||